Sphinx Pharmaceuticals

Research Triangle Park, NC

Ticker: Nasdaq: LLY


Sphinx was dedicated to drug discovery and development by generating combinatorial libraries and high throughput screening of compounds against biological targets central to human diseases. The company went public and was subsequently acquired by Eli Lilly and Company.

Read Success Story